3D Medicines Inc HKEX:1244:
ZHANG JING RESIGNS AS CFO
LU XIAOHAO APPOINTED AS CFO
3D Medicines Inc Says Zhang Jing Resigns As CFO
Earlier from 3d Medicines
- 3D Medicines Says New Drug Application For First-Line Treatment Of Biliary Tract Cancer Of Envafolimab Accepted
- 3D Medicines Says Envafoimab Granted Orphan Drug Designation